researchdrivelogo.jpg
Global Medical Tourism Market Expected to Generate a Revenue of $142.2 Billion by 2026, Growing at a CAGR of 11.7% from 2019-2026 COVID-19 impact - Exclusive Report by Research Dive
14 sept. 2021 09h01 HE | Research Dive
New York, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to generate a revenue of $142.2 billion by 2026,...
Logo.png
Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET
30 août 2021 09h15 HE | Protagenic Therapeutics, Inc.
Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Protagenic...
Logo.jpg
Celsion Corporation to Hold Second Quarter 2021 Financial Results and Business Update Conference Call on Thursday, August 12, 2021
05 août 2021 08h00 HE | Celsion CORP
LAWRENCEVILLE, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,...
ARC logo.png
Ear Nose and Throat (ENT) Treatment Market Value Surpass To Reach US$ 30.2 Billion By 2028 Covering Covid-19 Analysis: Acumen Research and Consulting
03 août 2021 10h20 HE | Acumen Research and Consulting
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The Global Ear, Nose, and Throat (ENT) Treatment Market is expected to grow at a CAGR of around 5.5% from 2021 to 2028 and expected to reach around US$...
logo.gif
Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology
06 juil. 2021 09h00 HE | Auris Medical AG
Treatment of KRAS-driven colorectal cancer selected as first therapeutic indication for OligoPhore™ platformCompany to launch development program under project code AM-401 with aim of IND submission...
Inagene Logo.jpg
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing
08 juin 2021 07h00 HE | Inagene Diagnostics Inc.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Inagene Diagnostic Inc., a Canadian pharmacogenetic testing company, and Calian Group Ltd., one of Canada's largest national health services organizations,...
DDD-Dimensions-lockup-blk.jpg
Dimensions Health Centres Announces Closing of First Treatment Center on Maple Lake in the Algonquin Highlands
25 mai 2021 08h30 HE | Dimensions Health Centres
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Dimensions Health Centres (“Dimensions”), a psychedelic treatment company focused on inpatient treatment integrating neuroscience with traditional healing...
Philogen logo.png
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress
12 mai 2021 13h00 HE | Philogen
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress May 12, 2021 NidlegyTM on track for Phase III European trial in stage IIIB/C melanoma. Opening of additional...
Healing Transitions Receives Grant from SECU Foundation to Expand Women’s Campus
10 mai 2021 13h11 HE | State Employees' Credit Union (SECU)
RALEIGH, N.C., May 10, 2021 (GLOBE NEWSWIRE) -- A local non-profit seeking to raise campaign funds for the renovation and much-needed expansion of campus facilities in Raleigh has received a...
brsf.png
Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial
16 mars 2021 08h30 HE | Brain Scientific Inc.
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announces a collaboration...